DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
Stocks in this Quantisnow insightConsumer Discretionary · Health Care
Historical context for DSS
Across the 8 sessions after earlier DSS headlines, the stock closed higher 2 times and lower 6 times, with a median move of 1.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DSS | SPY |
|---|---|---|---|
| Sep 8, 2026 | DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations | -1.0% | -0.5% |
| Sep 4, 2026 | DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offeringand 1 other headline that session | -2.4% | -0.4% |
| Aug 17, 2026 | American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director | -0.6% | -0.5% |
| Jun 9, 2026 | DSS, Inc. Withdraws Registration Statement | +19.6% | -0.3% |
| May 11, 2026 | DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing | -0.9% | +0.2% |
| Apr 16, 2026 | DSS, Inc. Letter to Shareholders | +0.2% | +0.2% |
Quantisnow market dataAMEX
DSS
DSS Inc.
- Market cap
- 30-day
- Sector
- Consumer Discretionary
- Industry
- Containers/Packaging
Get push alerts for DSS
Full DSS profile on Quantisnow Follow DSS and get a push notification the moment its next story breaks.